A 52-year-old woman from rural India presents with progressive fatigue, weight gain of 8 kg over 6 months, and constipation. She reports feeling cold even in warm weather and has noticed dry, coarse skin and hair loss. On examination, her heart rate is 52 bpm, skin is cool and dry, and she has a non-tender diffuse goiter. Laboratory investigations show TSH 18.5 mIU/L (normal 0.4–4.0), free T4 0.8 ng/dL (normal 0.8–1.8), and total cholesterol 285 mg/dL. What is the most appropriate initial management?

Explanation

## Clinical Diagnosis This patient has **primary hypothyroidism** with classic features: elevated TSH, low-normal free T4, and symptoms of thyroid hormone deficiency (fatigue, weight gain, cold intolerance, bradycardia, dry skin, goiter). ## Management Principles **Key Point:** Levothyroxine (synthetic T4) is the gold standard first-line treatment for primary hypothyroidism. It has a long half-life (7 days), allowing once-daily dosing and steady-state achievement in 6–8 weeks. ### Dosing Strategy 1. **Initial dose:** Start low (25–50 mcg daily) in older patients or those with cardiac disease to avoid precipitating angina or arrhythmias 2. **Titration:** Increase by 25–50 mcg every 6–8 weeks based on TSH response 3. **Target:** TSH in the normal range (0.5–2.5 mIU/L for most patients) **Clinical Pearl:** In this 52-year-old woman with no cardiac symptoms and a stable presentation, starting at 25 mcg is conservative but appropriate; she will need gradual escalation to reach a maintenance dose of 75–150 mcg (typical range). ### Why Not Other Options? | Approach | Rationale Against | |----------|-------------------| | **Levothyroxine 100 mcg immediately** | Risk of over-replacement, cardiac stress, and overshooting TSH suppression; no clinical urgency here | | **T3 monotherapy** | T3 has short half-life (1.5 days), requires multiple daily doses, and causes fluctuating levels; not first-line | | **Combination T4/T3** | No evidence of superiority over T4 alone in primary hypothyroidism; adds complexity | **High-Yield:** The majority of hypothyroid patients achieve euthyroidism on levothyroxine monotherapy; combination therapy is reserved for specific scenarios (e.g., persistent symptoms despite adequate TSH suppression on T4 alone—rare and controversial). ## Monitoring - Recheck TSH and free T4 at 6–8 weeks - Adjust dose based on TSH response - Once stable, annual monitoring is sufficient **Tip:** Always take levothyroxine on an empty stomach (30–60 min before food) to maximize absorption; avoid concurrent iron, calcium, and proton pump inhibitors.